Elias Sayour

Elias Sayour’s patients inspire his pioneering mRNA cancer vaccine research.

Breakthrough mRNA research co-led by Elias Sayour, M.D., Ph.D., is featured on the cover of The Cancer Letter.

Check out our top stories of the year.

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers found.

Innovative research at the UF Health Cancer Center is making a meaningful difference for those affected by cancer.

Elias Sayour, M.D., Ph.D., was honored for his work using mRNA vaccines in brain cancer immunotherapy.

A trained biomedical engineer, Leighton Elliott, MD, was 11 hours away on a mission trip in Vietnam helping to fit patients with prosthetic legs when he learned his first child had been born. The news arrived via a frantic series of missed Skype calls, followed by a grainy photo of his…

The Phase I trials to treat medulloblastoma will be led by Duane Mitchell, M.D., Ph.D., and Elias Sayour, M.D., Ph.D.

An mRNA cancer vaccine developed at the University of Florida has attracted widespread news coverage.

The breakthrough by UF Health Cancer Center researchers now will be tested in a Phase 1 pediatric clinical trial for brain cancer.